Kai Lovis

5 Patents

• US124483812025

  Method for the Preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide by Racemate Separation by Means of Diastereomeric Tartaric Acid Esters

  Bayer Pharma Aktiengsellschaft

  0 cites
• US123981442025

  Photochemical Process for Producing (4r,4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxamide

  Bayer Aktiengesellschaft

  0 cites
• US123656792025

  Process for Producing Acyloxymethyl Esters of (4s)-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxylic Acid

  Bayer Aktiengesellschaft

  0 cites
• US123588772025

  Synthesis of 4-amino-5-methyl-1h-pyridin-2(1h)-on (intermediate Compound for the Synthesis of the MR Antagonist Finerenone) from 2-chloro-5-methyl-4-nitro-pyridine-1-oxide Using the Intermediate Compound 2-chloro-5-methyl-4-pyridinamine

  Bayer Pharma Aktiengesellschaft

  0 cites
• US120544812024

  Method for the Preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide by Racemate Separation by Means of Diastereomeric Tartaric Acid Esters

  Bayer Pharma Aktiengesellschaft

  0 cites